Transcript Price Volume Agreements in the Czech Republic

Price Volume Agreements
in the Czech Republic
Tomas Sechser
Daniela Rrahmaniova
Ministry of Health Czech Republic
Drug Policy Experience of Visegrad Group
countries, Warszava Oct 29-30, 2007
Agenda
a)
b)
c)
d)
Definitions
Statutary control
Price negotiations
Pricing procedures
CR PPR 29.10.2007 [email protected]
Price volume agreement
 Like a framewok agreement, a volume control
tool
 The price of a pharmaceutical is agreed between
public authorities and a manufacturer on the
basis of a forecast volume of sales.
 If the actual sales volume exceeds the the
forecast, the price of the pharmaceutical is
usually reviewed downwards.
[PPRI Glossary]
CR PPR 29.10.2007 [email protected]
Pricing policy
 Regulations or procedures used by
regulator (government authority) to set
or limit the amount paid by
purchachers or the amount received
by sellers (e.g. statutary control, price
negotiations)
[PPRI Glossary]
CR PPR 29.10.2007 [email protected]
Pricing policy
in the Czech Republic
 Statutary control
 Price negotiations
 Price Volume Agreement
[Amendment of Public Health insurance Act 2007 ]
CR PPR 29.10.2007 [email protected]
Statutary pricing
 For all pharmaceuticals
[Amendment of Public Health insurance Act 2007 ]
CR PPR 29.10.2007 [email protected]
Price negotiations
a)
b)
c)
d)
When the Insurance Fund agrees with
manufacturer on a concrete price, which should be
lower than maximum price
The agreement should be valid for the whole
pharmaceutical market in CR
In case of very expensive treatment, the agreement
covers both the price and the number of the treated
patients in specialized centres
The agreement is valid for 6 months, if number of
patients in need is higher than expected, the
exceeding costs are covered by the manufacturer
[Amendment of Public Health insurance Act 2007 ]
CR PPR 29.10.2007 [email protected]
Pricing procedures
 External price referencing (i.e. cross
reference pricing)
 ESP, PG, GR,ITA, FIN, SLO (other
EU countries)
 Internal price referencing
[Amendment of Public Health insurance Act 2007 ]
CR PPR 29.10.2007 [email protected]
Reference group
§ 39c
 group of medical products essentially
therapeutically interchangeable with a similar
efficacy and safety and with a similar clinical
use
[Amendment of Public health insurance Act 2007 ]
CR PPR 29.10.2007 [email protected]